T. Rowe Price Associates’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,683,954
| Closed | -$483M | – | 2675 |
|
|
2017
Q3 | $483M | Sell |
2,683,954
-2,431,685
| -48% | -$339M | 0.08% | 260 |
|
|
2017
Q2 | $530M | Buy |
5,115,639
+1,907,805
| +59% | +$156M | 0.1% | 239 |
|
|
2017
Q1 | $252M | Buy |
3,207,834
+1,673,340
| +109% | +$103M | 0.05% | 377 |
|
|
2016
Q4 | $68.8M | Buy |
1,534,494
+1,012,926
| +194% | +$49.7M | 0.01% | 700 |
|
|
2016
Q3 | $29.1M | Buy |
521,568
+281,826
| +118% | +$15.7M | 0.01% | 995 |
|
|
2016
Q2 | $12M | Buy |
239,742
+224,752
| +1,499% | +$11M | ﹤0.01% | 1254 |
|
|
2016
Q1 | $688K | Buy |
14,990
+3,810
| +34% | +$185K | ﹤0.01% | 1845 |
|
|
2015
Q4 | $689K | Buy |
+11,180
| New | +$787K | ﹤0.01% | 1819 |
|
|
2015
Q3 | – | Sell |
-137,350
| Closed | -$8.37M | – | 2562 |
|
|
2015
Q2 | $8.37M | Buy |
+137,350
| New | +$7.84M | ﹤0.01% | 1389 |
|